Search - tctmd.com

Displaying 201 - 220 of 224

Sort: Relevancy | Date

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Todd Neale

December 04, 2017

News Conference News AHA 2017

Long-Awaited Hypertension Guidelines Released at AHA

Todd Neale

November 13, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Apples and Pears: Genetic Analysis Points to Causal Role for Belly Fat in Heart Disease and Diabetes

Yael L. Maxwell

February 14, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Daily News

Midlife Hypertension Linked to Late-Life Cognitive Decline

Leah Lawrence

October 11, 2016

News Daily News

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Michael O'Riordan

September 15, 2016

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

Newly Launched ACC Public Reporting Program Includes PCI Metrics, But No Mortality…For Now

L.A. McKeown

November 06, 2015

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

Advertisement

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Long-Awaited Hypertension Guidelines Released at AHA

New Performance and Quality Metrics for STEMI and NSTEMI Care

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

TCTMD’s Top 10 Most Popular Stories for May 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Apples and Pears: Genetic Analysis Points to Causal Role for Belly Fat in Heart Disease and Diabetes

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Midlife Hypertension Linked to Late-Life Cognitive Decline

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

TCTMD’s Top 10 Most Popular Stories for April 2016

Newly Launched ACC Public Reporting Program Includes PCI Metrics, But No Mortality…For Now

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content